Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 11 - 10 save search
Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs
Published: 2021-11-10 (Crawled : 23:00) - biospace.com/
OCX | News J | $2.495 -2.54% -2.61% 50K
|
Health Technology
|
| O: 0.29%
H: 3.77%
C: -2.9%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: -0.81%
H: 2.45%
C: -3.67%
financial results therapy results
Mustang Bio Announces Exclusive Worldwide License Agreement with Leiden University Medical Centre for Clinical-Stage Lentiviral Gene Therapy with Curative Potential for RAG1 Severe Combined Immunodeficiency
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: -1.57%
H: 2.39%
C: -1.2%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -1.95%
H: 1.42%
C: -2.27%
potential gene therapy therapy license
Secarna Pharmaceuticals and Achilles Therapeutics Sign Research, Option and License Agreement to Develop Optimized T Cell Therapies
Published: 2021-11-10 (Crawled : 14:00) - biospace.com/
ACHL | $0.7827 -2.16% -2.21% 200K
|
Manufacturing
|
| O: -3.69%
H: 3.46%
C: 0.45%
license research therapy t-cell
Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-10 (Crawled : 13:15) - biospace.com/
TSHA | $2.265 -6.02% -6.4% 1.8M
|
Health Technology
|
| O: 0.66%
H: 6.0%
C: 3.76%
financial results gene therapies results therapy gene therapy
Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery
Published: 2021-11-10 (Crawled : 13:00) - biospace.com/
ARAY | $2.135 -3.39% -3.51% 630K
|
Health Technology
|
| O: 4.76%
H: 3.67%
C: 1.92%
neurological therapy iot platform stereotactic radiosurgery
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
Published: 2021-11-09 (Crawled : 12:26) - renovorx.com
RNXT | $1.23 0.82% 0.81% 20K
|
|
| O: 67.28%
H: 38.23%
C: -9.83%
presentation treatment potential therapy cancer pancreatic pancreas
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.